Tuesday, May 29, 2018

Italy's clash with the euro may just be getting started

Relief among investors that two Italian populist parties failed to form a government has quickly given way to concerns that they could turn new elections later this year into a vote on the future of the euro.

Italian President Sergio Mattarella on Sunday refused to accept the nomination of a euroskeptic finance minister, prompting the anti-establishment Five Star Movement and far-right League party to give up trying to form an administration.

"Mattarella has made it clear that he will not allow any policy that could put Italy on a slippery slope towards a major confrontation with the [European Union] that could potentially jeopardize Italy's euro membership," wrote Holger Schmieding, chief economist at Berenberg bank, in a research note on Monday.

The euro edged higher early Monday along with Italian stocks and government bonds. They had come under heavy pressure in recent weeks because of fears that the populist parties' program of ��100 billion ($118 billion) in tax cuts and spending pledges could trigger a financial crisis in the heavily indebted nation and the wider eurozone.

But those gains evaporated quickly as markets focused on an uncertain future for Italy, a founding member of the euro currency and its third largest economy.

The main Italian stock market index was down by about 2% in early afternoon trading.

"The electoral process is back to square one with a lot of ill will," said Kit Juckes, a currency strategist at Societe Generale. "New elections are now more likely ... and the election itself is in danger of turning into a de facto referendum on euro membership."

Years of stagnation and a lack of reform have pushed Italy's government debt above ��2 trillion euros ($2.3 trillion), equivalent to more than 130% of annual economic output. That's the third highest level of indebtedness in the world after Japan and Greece.

Protecting the 'savings of Italians'

Mattarella said it was his duty to block the finance minister's appointment to protect the "savings of Italians."

"The uncertainty in our position in the euro has alarmed international and Italian investors and savers, who have invested in our government bonds and in our industries," Mattarella said Sunday.

"The surge of the [bond] spread, day after day, increases our public debt and it reduces government spending on social programs. The losses in the the stock market, day after day, burn the resources and savings of our industries and of those who have invested. And they amount to concrete risks for our fellow citizens and for Italian families," he added.

Italy has been without a government since elections in March. Mattarella's plan for a caretaker administration under former International Monetary Fund official Carlo Cottarelli may last only until a new vote can be held in October.

As a country that uses the euro, Italy has agreed to abide by EU budget rules designed to keep the currency stable. During the March election campaign, the populist parties called for those rules to be scrapped and talked about holding a referendum on the euro or leaving the European Union.

euro crossroads Analysts say the future of the euro could take center stage if Italy holds new elections later this year.

Those explosive pledges were missing from their draft government program, but analysts say they could now be revived as the populist parties blame Italy's political establishment for denying them the right to govern.

"It is also likely that the next election campaign will feature significantly stronger anti euro and euroskeptic tones," wrote Wolfango Piccoli, co-founder of Teneo Intelligence, in a research note Sunday.

"The League leader Matteo Salvini has already said that the next vote will be a 'referendum' to free Italy from the 'slavery regime' imposed by the [eurozone], Berlin, the markets and the [bond] spread," he added.

Too big to fail?

There's a huge amount at stake for Italy, and Europe.

Ratings agency Moody's warned Friday it could cut Italy's credit rating -- already just two notches above "junk" status -- because the populists' plans risked weakening its fiscal position and stalling efforts to reform the economy.

A rating downgrade would make it more costly for the Italian government to service its debts and raise the cost of new borrowing. Italy plans to issue about 250 billion euros ($292 billion) in bonds this year, according to Reuters.

Unlike Greece, which is just beginning to emerge from eight years of international bailouts, the Italian economy is big enough to throw the entire eurozone into disarray if it suffers a debt crisis. It accounts for about 15% of eurozone GDP and 23% of the region's government debt. Greece has just over 3% of eurozone public debt.

A louder campaign in Italy against Europe will keep investors on edge.

"Even if the immediate risk of having a euroskeptic finance minister in Italy has now been at least postponed, Italian uncertainties will continue to weigh heavily on sentiment in Italy and -- to a lesser extent -- its eurozone neighbors in coming months," wrote Berenberg's Schmieding.

Monday, May 28, 2018

Italian Markets Jump as President Vetoes Savona as Finance Chief

Italian bonds surged the most since September and stocks rallied after President Sergio Mattarella vetoed populist leaders’ choice of a euro-skeptic candidate for finance minister, fueling investor optimism that there are checks and balances in place that are working.

Ten-year yields slid as much as 12 basis points to 2.35 percent, narrowing the spread over German bunds by 14 basis points to 191. The FTSE MIB rose 1.7 percent in early trading, reversing Friday’s slide and crossing back above its 200-day moving average. The index is still down 7 percent from its peak reached on May 7. Italian banks led the rebound on Monday, with the FTSE All-Italia banks index rising 3.3 percent.

Mattarella became the target of populist rage when he said he rejected the populists’ choice of Paolo Savona for finance minister for the good of the country and the financial “savings of families” that had been endangered by rising bond spreads and market concerns.

“The market seems to cheer the news, but I don’t share the idea that a caretaker government is that reassuring,” Stephane Ekolo, equity strategist at TFS Derivatives, says by phone. “We might be off the cliff, but we are certainly not that far. We may have been witnessing the end of the 2nd republic in Italy.”

Share Share on Facebook Post to Twitter Send as an Email Print

Saturday, May 26, 2018

Rounds Report: Crispr Rallied While The FDA Approved Lumivascular

We have a passion for keeping things simple. - Charlie Munger

Trading Analytics

Welcome to this edition of Integrated BioSci Rounds Report for May 24, 2018. As usual, we��ll elucidate notable trading analytics for the day, recent insider transactions, and interesting market developments. Without further ado, let��s take an overall assessment of the bioscience space. As follows, the iShares of NASDAQ Biotechnology Index (NASDAQ:IBB) traded up by $0.53 (+0.50%) at $107.25. Moreover, the SPDR S&P Biotech (NYSE:XBI) exchanged hands $0.28 higher at $92.44 (for +0.30% gains). As witnessed, investors were trading with a positive sentiment for the day. Regardless of the daily inclination, there are substantial prospects in the bioscience sector: one that delivers hope for patients while rewarding supporters with substantial wealth in the long haul.

Figure 1: Notable BioSci movers (Source: Yahoo Finance)

Moving to specific equities, Crispr Therapeutics (NASDAQ:CRSP) won the highlight spot of the day. Accordingly, the stock moved $5.89 higher at $69.57 for over 9.1% profits. Headquartered in Zug Switzerland, Crispr is an innovator of gene-editing to potentially treat rare and life-threatening diseases. With strong underlying fundamentals, as reflective in the early preclinical data and other ongoing corporate developments, the stock procured over 255% for subscribers of Integrated BioSci Investing.

Notably, there are two gene-editing systems (zinc finger nuclease and CRISPR/Cas9). While both are excellent mechanisms of tinkering the genes to deliver novel therapeutics, we are most interested in the former (which is employed by Crispr). The main reason is that bacteria have employed CRISPR for millions of years and thereby fine-tuned it directly via evolution. By harnessing the power of CRISPR/Cas9, it��s highly favorable that the lead molecule (CTX-001) will deliver strong results for the beta-thalassemia franchise. Reflective of a company gearing up for its next growth phase, Crispr has been streamlining its management team. Going forward, we expect more fortunes for other gene editing and gene therapy innovators as featured in the Specialty Report.

Figure 2: CRISPR/Cas9 (Source: Crispr Therapeutics)

Bioscience Catalysts

On May 23, 2018, Avinger (NASDAQ:AVGR), announced that the FDA approved the 510(NYSE:K) for its next-generation Pantheris Lumivascular atherectomy system. This is an unprecedented image-guided device that removes the plaque inside the artery (atherectomy), indicated for the treatment of the common condition, peripheral artery disease (��PAD��). In response, the shares of the $10.55M (micro-cap stock) shot up over 73%.

Of note, Lumivascular is the only technology with real-time imaging inside the artery for highly effective catheters treatment of PAD. The aforesaid condition is estimated to occur in more than 21M Americans by 2020. With the approval, this grower is positioned to profit from the highly prevalent condition. Thrilled with the aforesaid development, the Present and CEO (Jeff Soinski) enthused,

We are excited to introduce the next generation Pantheris to our network of physicians here in the US. After extensive testing by our R&D and operations teams, physician design validation, and successful initial case experience in Europe across a variety of different lesion types, we believe this next generation device will significantly improve the user experience in terms of reliability, efficiency, and ease of use across a spectrum of clinical situations.

The approval delivers hopes to countless American suffering from PAD - a condition that tends to occur with heart disease, obesity, and diabetes. And, it��s prevalence is growing as we��re writing this report. Asides from the medical view, this milestone delivers increasing wealth for the shareholders. Hence, it��s not a bad idea to initiate a small pilot position in this company to potentially profit from the further upsides.

Final Remarks

In all, the bioscience market continued to amass further profits for investors. Many companies under our coverage rallied. The most notable is Crispr Therapeutics. As one of the leaders in gene-based therapy, the company revealed the stellar early preclinical data. The future clinical binary for the beta-thalassemia franchise is highly likely to be positive. The company is also streamlining its management. Last but not least, the FDA approval of Lumivascular to deliver hopes for patients suffering from PAD while rewarding shareholders with substantial gains.

Author��s Notes: We��re honored that you took the time to read our market intelligence. Founded by Dr. Hung Tran, MD, MS, CNPR, (in collaborations with Analyst Vu, and other PhDs), Integrated BioSci Investing (��IBI��) is delivering stellar returns. To name a few, Nektar, Spectrum, Atara, and Kite procured over 328%, 148%, 264%, and 83% profits, respectively. Our secret sauce is extreme due diligence with expert data analysis. The service features a once-weekly exclusive Alpha-Intelligence article, daily analysis/consulting, and model portfolios. Of note, there is an IBI version of this article that is a higher-level intelligence with extensive details, in which we published in advanced and exclusively for our subscribers. And, we invite you to subscribe to our marketplace now to lock in the current price and save money for the future.

Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.

I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Additional disclosure: Our research articles are best used as starting points in your own due diligence. We are not registered investment advisors and our articles are not construed as professional investment advice. Many new research are requests from private investors of our services (Integrated BioSci Investing and Dr. Tran BioSci), who either paid or donated us to support our efforts (in assisting investors and bioscience innovators to deliver hopes to patients). That aside, I like to inform readers of Seeking Alpha's recent policy change, in which the company implemented the paywall (not only to our articles but to all articles that are published over 10-day). This is in place, as the company is, after all, a business. And, the revenues from ads are not adequate to support the high-quality research that the company is providing. If you are a REAL TIME FOLLOWER, you will be notified immediately of our new research for you to continue to benefit from our due diligence. You can also gain access to all of my old articles and much more by taking the 2-week FREE trial of my marketplace, Integrated BioSci Investing.

Friday, May 25, 2018

Canada��s ��Unprecedented�� Reliance on Housing Fuels Recession Call

This recession call is coming from inside the house.

The Bank of Canada has highlighted elevated household debt and imbalances within the nation’s real estate market as the two chief vulnerabilities to the financial system in the event of a recession.

But what could trigger such a downturn? Macquarie Capital Markets offers one simple answer: the housing market itself -- highlighting that the share of employment tied to construction as well as finance, insurance and real estate is nearly two standard deviations above its long-term average.

#lazy-img-328065795:before{padding-top:56.25%;}

Tighter mortgage rules and higher interest rates have weighed on activity in formerly high-flying Canadian housing markets, with home sales in Toronto having their worst start to the year since 2009.

“For downside risks to be realized, however, any potential housing-related weakness must spill over into the labor market,” analyst David Doyle wrote in a note to clients Thursday. “While rising rates put pressure on consumer finances, job losses trigger defaults and a tightening in credit conditions that can lead to more severe economic outcomes.”

Roughly half of all economic weakness during recessions since World War II is tied to fluctuations in residential investment, he calculates, and the extent to which Canadian output and employment are currently reliant on this is “unprecedented.”

Macquaire’s best-case scenario is that the fallout, starting in 2020, will be as bad for Canada as the 2008-09 financial crisis. Worst case: The unemployment rate will spike by more than any recession since the Great Depression.

#lazy-img-328066108:before{padding-top:88.70056497175142%;}

In terms of employment concentration in housing-linked industries, this dependency is particularly pronounced in Ontario and British Columbia but still prevalent across the rest of the country. Job growth in these sectors has come amid shrinking payrolls in other cyclical areas like manufacturing, making “housing an all the more important driver of the Canadian business cycle,” Doyle said.

The strength in housing starts and consumer spending, however, suggest only a “modest” risk of a housing-led recession in the nearer-term, according to the analyst.

Macquarie sees the U.S. dollar rising to C$1.36 relative to its Canadian counterpart by the end of 2019. Housing-related risks inform the bank’s stance to overweight outward-facing segments of the S&P/TSX Composite (like energy, technology and industrials) while underweighting areas with immense domestic ties (banks, consumer and telecom).

LISTEN TO ARTICLE 2:21 Share Share on Facebook Post to Twitter Send as an Email Print

Thursday, May 24, 2018

Top 10 Gold Stocks To Buy For 2019

tags:CIM,XIV,PLUG,COTV,ROG,ICAD,WM,MMM,CYBE,TU,

It was yet another down day for stocks, with the Dow plunging almost 139 points and the big indexes sliding for a second consecutive week.

Traders work on the floor at the closing bell. Agence France-Presse/Getty Images

The Dow Jones Industrial Average slid 138.6 points, or 0.67%, to end at 20453.25. The S&P 500 Index was down almost 16 points, or 0.68% to 2328.95. The Nasdaq fell more than 31 points, or 0.53%, to 5805.15.

Blame it on flaring geopolitical tensions and light market action ahead of the Easter holiday weekend overshadowing the estimate-beating earnings reports from J.P. Morgan Chase (JPM) and Citigroup (C).

The big news today: the U.S. dropped its biggest non-nuclear bomb on a suspected ISIS tunnel complex in Afghanistan.

The WSJ reported that declines today were across all sectors. Investors dumped financial and industrial companies while retreating to haven investments like Treasuries and gold.

Top 10 Gold Stocks To Buy For 2019: Chimera Investment Corporation(CIM)

Advisors' Opinion:
  • [By Shane Hupp]

    Public Employees Retirement Association of Colorado trimmed its position in shares of Chimera Investment Co. (NYSE:CIM) by 18.0% during the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 51,307 shares of the real estate investment trust’s stock after selling 11,267 shares during the period. Public Employees Retirement Association of Colorado’s holdings in Chimera Investment were worth $893,000 at the end of the most recent reporting period.

Top 10 Gold Stocks To Buy For 2019: region(XIV)

Advisors' Opinion:
  • [By Money Morning News Team]

    This led some traders to purchase leveraged ETFs that move inverse to the VIX, like the�VelocityShares Daily Inv VIX Short Term�(Nasdaq: XIV).

    The VIX is a derivative of the broad S&P 500, and the XIV is a derivative of that derivative.

Top 10 Gold Stocks To Buy For 2019: Plug Power Inc.(PLUG)

Advisors' Opinion:
  • [By Maxx Chatsko]

    Fuel cell manufacturer Plug Power (NASDAQ:PLUG) has done relatively little since going public all the way back in 1999. Then again, maybe it's all about timing.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Plug Power (PLUG)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Maxx Chatsko]

    That much becomes clear after taking a look at fuel cell stocks Plug Power (NASDAQ:PLUG) and Ballard Power Systems (NASDAQ:BLDP). The companies generated just $235 million in revenue combined last year. While that would seem to indicate that the technology has a ways to go, a closer look shows both companies are on an upward trajectory as they position to exploit decarbonization trends. It also reveals two different growth strategies.

Top 10 Gold Stocks To Buy For 2019: Cotiviti Holdings, Inc. (COTV)

Advisors' Opinion:
  • [By Max Byerly]

    Cotiviti Holdings, Inc. (NYSE:COTV) – Equities research analysts at Jefferies Group lowered their FY2018 earnings estimates for Cotiviti in a report issued on Wednesday, May 2nd. Jefferies Group analyst S. Dodge now expects that the business services provider will post earnings per share of $1.68 for the year, down from their previous estimate of $1.71. Jefferies Group also issued estimates for Cotiviti’s FY2019 earnings at $1.87 EPS.

Top 10 Gold Stocks To Buy For 2019: Rogers Corporation(ROG)

Advisors' Opinion:
  • [By Stephan Byrd]

    Rogers (NYSE: ROG) and Kraton (NYSE:KRA) are both computer and technology companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, profitability, dividends, institutional ownership, valuation, analyst recommendations and earnings.

Top 10 Gold Stocks To Buy For 2019: icad inc.(ICAD)

Advisors' Opinion:
  • [By Lisa Levin]

     

    Losers Netshoes (Cayman) Limited (NASDAQ: NETS) shares dipped 43.73 percent to close at $2.87 on Tuesday as the company posted downbeat Q1 results. Cesca Therapeutics Inc. (NASDAQ: KOOL) shares dropped 29.01 percent to close at $0.80 after reporting Q1 results. SenesTech, Inc. (NASDAQ: SNES) shares fell 22.2 percent to close at $0.340 after reporting Q1 miss. Vipshop Holdings Limited (NYSE: VIPS) fell 19.95 percent to close at $12.08 after the company reported weaker-than-expected earnings for its first quarter on Monday. Image Sensing Systems, Inc. (NASDAQ: ISNS) fell 19.68 percent to close at $3.775 after reporting earnings were down year over year. First quarter earnings came in flat, down from 4 cents per share in the same quarter of last year. Sales came in at $3.01 million. Boxlight Corporation (NASDAQ: BOXL) dropped 18.47 percent to close at $9.62 on Tuesday after surging 77.44 percent on Monday. ENDRA Life Sciences Inc. (NASDAQ: NDRA) declined 16.21 percent to close at $2.43. ENDRA Life Sciences is expected to release quarterly earnings today. ALJ Regional Holdings, Inc. (NASDAQ: ALJJ) shares fell 16.13 percent to close at $1.79. Switch Inc (NYSE: SWCH) shares dropped 14.93 percent to close at $13.16 following a first-quarter earnings miss. Restoration Robotics Inc (NASDAQ: HAIR) fell 14.42 percent to close at $3.68 after reporting a first-quarter earnings miss. iCAD, Inc. (NASDAQ: ICAD) declined 13.01 percent to close at $3.41 following Q1 results. Intersections Inc. (NASDAQ: INTX) fell 12.44 percent to close at $1.97. Histogenics Corporation (NASDAQ: HSGX) declined 12.24 percent to close at $2.15. AZZ Inc. (NYSE: AZZ) fell 12.1 percent to close at $39.60 following Q3 earnings. Hallador Energy Company (NASDAQ: HNRG) fell 11.1 percent to close at $6.49. Integrated Media Technology Limited (NASDAQ: IMTE) dropped 10.66 percent to close at $16.93 on Tuesday. Myomo, Inc. (NYSE: MYO) slipp

Top 10 Gold Stocks To Buy For 2019: Waste Management, Inc.(WM)

Advisors' Opinion:
  • [By Stephan Byrd]

    KAMES CAPITAL plc grew its stake in shares of Waste Management (NYSE:WM) by 26.3% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 25,022 shares of the business services provider’s stock after buying an additional 5,215 shares during the period. KAMES CAPITAL plc’s holdings in Waste Management were worth $2,105,000 as of its most recent filing with the Securities and Exchange Commission.

  • [By Tyler Crowe, Reuben Gregg Brewer, and Travis Hoium]

    Finding investments that can reward you over such long periods can do miracles for your portfolio -- as long as you can find the right ones. So we asked three Motley Fool investors to highlight a stock they see as a great investment with solid growth prospects over the next 25 years. Here's why they picked W.W. Grainger (NYSE:GWW), Wynn Resorts (NASDAQ:WYNN), and Waste Management (NYSE:WM).

  • [By ]

    For his "Executive Decision" segment, Cramer spoke with Jim Fish, president and CEO of Waste Management (WM) , which just posted an eight-cents-a-share earnings beat, but saw shares decline as investors worry over the impact of trade wars with China on the company's recycling business.

  • [By Max Byerly]

    Becker Capital Management Inc. purchased a new stake in shares of Waste Management (NYSE:WM) during the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 10,320 shares of the business services provider’s stock, valued at approximately $868,000.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Waste Management (WM)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Gold Stocks To Buy For 2019: 3M Company(MMM)

Advisors' Opinion:
  • [By ]

    Bulls were stampeded on Tuesday.  The Dow Jones Industrial Average  lost 424 points, or 1.74%, the S&P 500  handed over 1.34% and the Nasdaq Composite   shed 1.68%. For some investors, the losses might have come as a surprise amid solid first-quarter earnings reports from bellwether companies like Caterpillar (CAT) , United Technologies (UTX) , Coca-Cola (KO) and 3M (MMM) . You need to be at TheStreet's May 5 boot-camp for investors. Learn more here.

    But, it was cautious comments by Caterpillar execs on the demand outlook for the rest of 2018 during an earnings call that sent the bears out of hibernation. Not helping market sentiment were 10-year yields topping the 3% mark for the first time in more than four years. 

  • [By ]

    The Caterpillar news was followed by 3M (MMM) , which lowered full-year guidance, sending its shares down 6.8%. Lockheed Martin (LMT) then delivered blowout earnings, but mentioned that its cash flow might be challenged. Shares fell 6.1%.

  • [By ]

    Selected examples: (AAL) , (CL) , (DRI) , (HAL) , (LUV) , (MCD) , (MMM) , (SBUX) . Darden and 3M are holdings in Jim Cramer's Action Alerts PLUS.

    What Trade War?

    Notes Goldman: "Firms expressed optimism that trade conflict would be resolved. Commentary emphasized the support for a free trade environment. Company management did not expect the disputes would escalate and affect global economic growth."

  • [By Garrett Baldwin]

    Markets are keeping a close eye on the 10-year bond, which is hovering near 3% – an important psychological level that is likely to influence future price movements. On Monday, Fox Business Network's "Varney & Co." asked Money Morning Chief Investment Strategist Keith Fitz-Gerald if investors should be worried. Here's what Keith had to say about the 10-year Treasury yield… and how it will affect your stocks and bonds in the future. The price of Brent crude oil topped $75.00 and hit its highest level since November 2014. Oil traders were eyeing the ongoing efforts of OPEC and Russia to reduce excessive production around the globe, rising demand ahead of peak driving season, and the possibility that the Trump administration will slap Iran with a new round of sanctions. Three Stocks to Watch Today: KO, GOOGL, SLM Shares of The Coca-Cola Co.�(NYSE: KO) added 1.2% after the firm easily beat earnings and revenue expectations. The firm cited strong demand for its new flavors of Diet Coke and its Coke Zero Sugar. Demand was so strong for the quarter that the firm reported organic sales growth of 5%. The company reported earnings per share of $0.47, topping estimates by a penny. Revenue of $7.6 billion easily beat Wall Street estimates. Shares of Alphabet Inc. (Nasdaq: GOOGL) seesawed in pre-market hours. The online search giant topped Wall Street earnings and revenue expectations after the bell Monday. However, shares were off 0.5% after executives announced that its business costs were on the rise. The firm's real estate and computer purchases tripled in one year, to $7.3 billion. About one-third of that total came from its $2.4 billion purchase of the Chelsea Market building in New York City. Good news for SLM Corp.�(NYSE: SLM) investors, but bad news for indebted college students and graduates. The firm – also known as Sallie Mae – topped Wall Street earnings expectations on Monday. The firm said that it increased its loan o

Top 10 Gold Stocks To Buy For 2019: CyberOptics Corporation(CYBE)

Advisors' Opinion:
  • [By Ethan Ryder]

    Perceptron (NASDAQ: PRCP) and CyberOptics (NASDAQ:CYBE) are both small-cap computer and technology companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, risk, earnings, dividends and valuation.

Top 10 Gold Stocks To Buy For 2019: TELUS Corporation(TU)

Advisors' Opinion:
  • [By Ethan Ryder]

    LSV Asset Management reduced its position in Telus (NYSE:TU) (TSE:T) by 42.5% in the 1st quarter, HoldingsChannel reports. The fund owned 112,500 shares of the Wireless communications provider’s stock after selling 83,000 shares during the quarter. LSV Asset Management’s holdings in Telus were worth $3,955,000 at the end of the most recent quarter.

Tuesday, May 22, 2018

Starbucks (SBUX) Shares Bought by Douglass Winthrop Advisors LLC

Douglass Winthrop Advisors LLC raised its stake in Starbucks (NASDAQ:SBUX) by 25.1% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 559,223 shares of the coffee company’s stock after acquiring an additional 112,110 shares during the period. Starbucks accounts for approximately 1.6% of Douglass Winthrop Advisors LLC’s portfolio, making the stock its 25th largest position. Douglass Winthrop Advisors LLC’s holdings in Starbucks were worth $32,373,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Argus Investors Counsel Inc. boosted its stake in Starbucks by 1.2% in the fourth quarter. Argus Investors Counsel Inc. now owns 72,413 shares of the coffee company’s stock valued at $4,159,000 after acquiring an additional 866 shares in the last quarter. Dorsey & Whitney Trust CO LLC boosted its stake in Starbucks by 8.9% in the first quarter. Dorsey & Whitney Trust CO LLC now owns 10,863 shares of the coffee company’s stock valued at $629,000 after acquiring an additional 884 shares in the last quarter. MAI Capital Management boosted its stake in Starbucks by 4.5% in the fourth quarter. MAI Capital Management now owns 21,389 shares of the coffee company’s stock valued at $1,228,000 after acquiring an additional 912 shares in the last quarter. V Wealth Management LLC boosted its stake in Starbucks by 8.6% in the fourth quarter. V Wealth Management LLC now owns 11,542 shares of the coffee company’s stock valued at $680,000 after acquiring an additional 914 shares in the last quarter. Finally, Laurel Wealth Advisors Inc. boosted its stake in Starbucks by 6.6% in the third quarter. Laurel Wealth Advisors Inc. now owns 15,542 shares of the coffee company’s stock valued at $834,000 after acquiring an additional 960 shares in the last quarter. Institutional investors own 74.78% of the company’s stock.

Get Starbucks alerts:

NASDAQ SBUX opened at $57.16 on Monday. The stock has a market cap of $78.88 billion, a P/E ratio of 27.75, a PEG ratio of 1.64 and a beta of 0.63. Starbucks has a 52-week low of $52.58 and a 52-week high of $64.87. The company has a debt-to-equity ratio of 1.31, a current ratio of 1.09 and a quick ratio of 0.83.

Starbucks (NASDAQ:SBUX) last posted its quarterly earnings results on Thursday, April 26th. The coffee company reported $0.53 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.53. The firm had revenue of $6.03 billion during the quarter, compared to analysts’ expectations of $5.93 billion. Starbucks had a net margin of 18.71% and a return on equity of 60.33%. The firm’s revenue for the quarter was up 13.9% on a year-over-year basis. During the same period in the prior year, the company posted $0.45 earnings per share. sell-side analysts predict that Starbucks will post 2.49 EPS for the current fiscal year.

Starbucks declared that its Board of Directors has authorized a stock repurchase program on Thursday, April 26th that authorizes the company to buyback 0 outstanding shares. This buyback authorization authorizes the coffee company to repurchase shares of its stock through open market purchases. Stock buyback programs are usually a sign that the company’s management believes its stock is undervalued.

The company also recently declared a quarterly dividend, which will be paid on Friday, May 25th. Investors of record on Thursday, May 10th will be issued a dividend of $0.30 per share. The ex-dividend date is Wednesday, May 9th. This represents a $1.20 annualized dividend and a yield of 2.10%. Starbucks’s dividend payout ratio is currently 58.25%.

In other Starbucks news, Director Craig Weatherup sold 59,838 shares of the company’s stock in a transaction dated Tuesday, March 13th. The shares were sold at an average price of $60.10, for a total transaction of $3,596,263.80. Following the transaction, the director now directly owns 26,500 shares in the company, valued at $1,592,650. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 3.40% of the company’s stock.

SBUX has been the subject of a number of research reports. Wedbush reaffirmed a “buy” rating and issued a $70.00 target price on shares of Starbucks in a report on Monday, January 22nd. They noted that the move was a valuation call. Goldman Sachs cut shares of Starbucks from a “conviction-buy” rating to a “buy” rating and reduced their target price for the company from $73.00 to $68.00 in a report on Friday, January 26th. BMO Capital Markets upped their target price on shares of Starbucks to $58.00 and gave the company a “market perform” rating in a report on Friday, January 26th. BTIG Research reaffirmed a “buy” rating and issued a $64.00 target price on shares of Starbucks in a report on Friday, January 26th. Finally, Deutsche Bank reaffirmed a “buy” rating and issued a $63.00 target price on shares of Starbucks in a report on Friday, January 26th. One investment analyst has rated the stock with a sell rating, fourteen have assigned a hold rating and eighteen have assigned a buy rating to the company. The company presently has an average rating of “Buy” and an average price target of $64.25.

About Starbucks

Starbucks Corporation, together with its subsidiaries, operates as a roaster, marketer, and retailer of specialty coffee worldwide. The company operates in four segments: Americas; China/Asia Pacific; Europe, Middle East, and Africa; and Channel Development. Its stores offer coffee and tea beverages, roasted whole bean and ground coffees, single-serve and ready-to-drink coffee and tea products, and food and snacks; and various food products, such as pastries, breakfast sandwiches, and lunch items.

Want to see what other hedge funds are holding SBUX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Starbucks (NASDAQ:SBUX).

Institutional Ownership by Quarter for Starbucks (NASDAQ:SBUX)

Sunday, May 20, 2018

The Clorox Company (CLX) Stake Lessened by US Bancorp DE

US Bancorp DE lowered its stake in shares of The Clorox Company (NYSE:CLX) by 1.1% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 170,734 shares of the company’s stock after selling 1,894 shares during the quarter. US Bancorp DE owned about 0.13% of The Clorox worth $22,726,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Centaurus Financial Inc. acquired a new position in shares of The Clorox during the first quarter valued at about $106,000. Prime Capital Investment Advisors LLC acquired a new position in shares of The Clorox during the fourth quarter valued at about $123,000. Tiemann Investment Advisors LLC acquired a new position in shares of The Clorox during the fourth quarter valued at about $200,000. Nicholas Hoffman & Company LLC. acquired a new position in shares of The Clorox during the fourth quarter valued at about $201,000. Finally, Lourd Capital LLC acquired a new position in shares of The Clorox during the fourth quarter valued at about $210,000. Hedge funds and other institutional investors own 76.39% of the company’s stock.

Get The Clorox alerts:

The Clorox opened at $118.33 on Friday, Marketbeat reports. The company has a debt-to-equity ratio of 2.14, a quick ratio of 0.93 and a current ratio of 1.18. The Clorox Company has a 12 month low of $117.44 and a 12 month high of $118.56. The company has a market capitalization of $15.33 billion, a price-to-earnings ratio of 22.12, a P/E/G ratio of 2.65 and a beta of 0.37.

The Clorox (NYSE:CLX) last released its quarterly earnings data on Wednesday, May 2nd. The company reported $1.37 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.31 by $0.06. The Clorox had a return on equity of 107.93% and a net margin of 13.27%. The business had revenue of $1.52 billion for the quarter, compared to analyst estimates of $1.51 billion. During the same quarter in the prior year, the firm posted $1.31 EPS. The business’s quarterly revenue was up 2.7% compared to the same quarter last year. sell-side analysts expect that The Clorox Company will post 5.73 earnings per share for the current year.

Several brokerages recently weighed in on CLX. Barclays reiterated a “hold” rating and issued a $135.00 price target on shares of The Clorox in a report on Friday, March 16th. Bank of America cut their price target on shares of The Clorox from $140.00 to $130.00 and set a “hold” rating on the stock in a report on Thursday, May 3rd. BMO Capital Markets set a $147.00 price target on shares of The Clorox and gave the stock a “buy” rating in a report on Monday, February 5th. Wells Fargo cut their price target on shares of The Clorox from $140.00 to $130.00 and set a “market perform” rating on the stock in a report on Thursday, April 19th. Finally, Zacks Investment Research downgraded shares of The Clorox from a “buy” rating to a “hold” rating in a report on Monday, January 22nd. Three analysts have rated the stock with a sell rating, ten have given a hold rating and two have assigned a buy rating to the company. The Clorox presently has a consensus rating of “Hold” and an average target price of $130.98.

About The Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighters and color boosters; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning and disinfecting products under the Clorox, Dispatch, Aplicare, HealthLink, and Clorox Healthcare brands.

Institutional Ownership by Quarter for The Clorox (NYSE:CLX)